Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Mind Medicine Inc MNMD
(Total Views: 93)
Posted On: 09/11/2025 9:20:05 PM
Post# of 87
Posted By: teabiscuitbreeder
MM120 Effective as a Single Dose for Generalized Anxiety Disorder: Phase 2b Results | HCP Live

Investigator Maurizio Fava, MD, chair of Mass General Brigham, discusses how MindMed’s MM120 (lysergide D-tartrate, LSD) at 100 μg signficantly reduces anxiety in adults with generalized anxiety disorder (GAD).

https://www.hcplive.com/shorts/mm120-effectiv...2b-results

Mass General was one of the first providers in the US who offered IV ketamine for depressed people. I predict that will be one of the first adopters of this treatment as well













(0)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site